Therapy Areas: Hereditary Disorders
23 November 2020 - Aridis Pharmaceuticals Inc (Nasdaq: ARDS), a biopharmaceutical company, has reported its financial results for the first nine months of fiscal 2020, it was reported on Friday.The co...
16 November 2020 - Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company, has received the Priority Medicines (PRIME) designation from the European Medicines Agency (EMA) for its bren...
10 November 2020 - - US-based nonprofit the Cystic Fibrosis Registry Global Harmonization Group, including the CF Foundation, has published in the Journal of Cystic Fibrosis updated data on ...
27 October 2020 - The United States Food and Drug Administration (FDA) has approved the Investigational New Drug application (NDA) from Vanda Pharmaceuticals Inc (Nasdaq: VNDA), a specialty pharmaceut...
8 September 2020 - Biopharmaceutical company Aridis Pharmaceuticals Inc (Nasdaq:ARDS) on Tuesday announced an agreement with the US Food and Drug Administration (FDA) to simplify its AR-501 Phase 2 tr...